BITS Pilani

  • Page last updated on Friday, October 29, 2021

Invited Lectures

banner
Invited Lectures

Some list of Lectures

  • ‘Synthetic Uses of Chlorosulfonyl Isocyanate for Heterocyclic Compounds’, University of Portsmouth, England, U.K (March 1989). 
  • ‘Enzyme as Biocatalysts in Organic Synthesis Present and Future’, Lupin Laboratories, R&D, Ankleshwar, Gujarat (March 1990).
  • ‘Biocatalysis in Organic Synthesis’, Southern Petrochemical Industries Corporation Ltd. (SPIC) – Pharma R&D, Madras (November 1991).
  • ‘Molecular Recognition of DNA by Pyrrolobenzodiazepine Antibiotics’ in the meeting on ‘Molecular Recognition: Chemical and Biological Aspects’, Jawaharlal Nehru Centre for Advanced Scientific Research, IISc, Bangalore (October 1992).
  • ‘Synthesis of Podophyllotoxin Congeners as Potential DNA Topoisomerase II Inhibitors’ at 10th International Conference on Organic Synthesis, Bangalore (December 1994).
  • ‘New Podophyllotoxin Analogues as DNA-Topoisomerase Inhibitors’, at Ranbaxy Research Laboratory, New Delhi (August 1995).
  • IICT-Industry Interaction, Hyderabad (November 1996).
  • ‘Enzymes as Biocatalysts in Organic Synthesis’ at the Anwar-Ul-Ullom College for Postgraduate Studies, Hyderabad (March 1996).
  • ‘New Synthetic Strategies for the Pyrrolobenzodiazepine Antibiotics’ at Sixth National Organic Symposium Trust (NOST), Lonavala (April 1997).
  • ‘Application of Biotransformations in the Synthesis of Biologically Important Components’ at National Seminar on ‘Perspective Areas of Chemistry and Biology’, DelhiUniversity, (January 1998).
  • National Seminar on ‘Cancer-Recent Trends in Drug Development & Therapy’, KakatiyaUniversity, Warangal (March 1999). 
  • ‘Design Synthesis and Antitumour Activity of New DNA Interactive Pyrrolo[2,1-c]-[1,4]benzodiazepines’ at Fifth IUPAC International Symposium on Bio-organic Chemistry (ISBOC-5), Pune (January 2000).
  • ‘Chemoenzymatic Synthesis of Biologically Important Compounds’ at OsmaniaUniversity (October 2000).
  • ‘Synthesis and Anticancer Potential of DNA Interactive Heterocycles’ at OsmaniaUniversity (October 2000).
  • ‘Design and Synthesis of Heterocyclic Compounds with Potential Antitubercular Activity’ at Lupin Laboratories, Mumbai (January 2001).
  • Enzyme Assisted Organic Synthesis’ at OsmaniaUniversity (October 2001).
  • ‘Synthesis and Structure Activity Relationship of DNA Binding Heterocycles’ at Osmania University (October 2001).
  • ‘Pyrrolobenzodiazepines as Anticancer Agents’ at University of Hyderabad (November 2001).
  • ‘Biotransformations in Organic Synthesis’ at JNTU, Hyderabad (November 2002).
  • ‘Drug Design and Development’ at University of Hyderabad (November 2002).
  • ‘Design and Synthesis of Antitumour Antibiotics’, Buchi Laboratories, Switzerland (January 2003).
  • ‘Solid Phase Synthesis of Pyrrolobenodiazepines’ Basel, Switzerland (January 2003).
  • ‘Enzyme Mediated Transformations’, University of Bern, Switzerland (January 2003).
  • ‘New Hybrids of Pyrrolobenzodiazepines’, KakatiyaUniversity, Warangal (February 2003).
  • ‘Gene-targeting Pyrrolobenzodiazepines’, at IUPAC International Conference on Biodiversity and Natural Products: Chemistry and Medical Application (January 2004).
  • ‘Gene-targetting Pyrrolobenzodiazepines as Potential Anticancer Agents’ at Anti-Cancer Drug Development, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Navi Mumbai (January 2004).
  • ‘New Pyrrolobenzodiazepine Hybrids with Remarkable DNA-Binding Affinity’ at 5th Annual Symposium on Frontiers in Biomedical Research, New Delhi (April 2004).
  • ‘Development of New Anticancer Agents’, Department of Chemistry, GulbargaUniversity (July 2004).
  • ‘Bioinformatics in Drug Discovery Process’, popular talk at “INDISPENSABILISSCIENTIA”, Muffakham Jha College of Engineering and Technology, Hyderabad (September 2004).
  • ‘Synthesis of Bioactive Molecules Employing Biocatalytic Processes’, Merck- Lecture, University of Cape Town, South Africa (March 2005).
  • ‘Solution and Solid Phase Synthesis of Pyrrolobenzodiazepines’, Bergische Universität-GH Wuppertal, Germany (May 2005).
  • ‘Design and Synthesis of Novel Pyrrlobenzodiazepine Hybrids as Potential Chemotherapeutic Agents’, Grober Hörsaal des Instituts für Chemie und Biochemie, Universität Greifswald, Germany (May 2005).
  • ‘New Podophyllotoxin Congeners as Potential Anticancer Agents’, Technische Universität Dresden, Germany (May 2005).
  • ‘Development of Synthetic Strategies for Pyrrolo[2,1-c][1,4]benzodiazepines in Solution and Solid Phase’, Bayer Healthcare AG, Wuppertal, Germany (May 2005).
  • ‘Hybrids of Pyrrolo[2,1-c][1,4]benzodiazepines as Potential Antitumour agents’, at National Conference on Chemistry in Drug Industry, National Institute of Warangal, Warangal, India (October 2005).
  • ‘Development of Greener Procedures for the Synthesis of Biologically Important Compounds’, DST sponsored Workshop on Green Chemistry Perspectives, Nirma Institute of Science and Technology, Ahmedabad (November 2005).
  • ‘Lipases: Enzymes for Biocatalytic Enantioselective Synthesis’, IUPAC sponsored Second International Symposium on Green/Sustainable Chemistry, University of Delhi, Delhi (January 2006).
  • ‘Design and Synthesis of New Pyrrolobenzodiazepines as DNA-Interactive Anticancer Agents’, Eighth CRSI National Symposium in Chemistry, IIT Bombay, Mumbai (February 2006).
  • ‘Development of DNA-Binding Anticancer Agents’, TheMERCK Seminar Programme, The University of Cape Town, South Africa (February 2006).
  • ‘Design and Combinatorial Synthesis of Potential Anticancer Agents’, National Symposium on Challenges in Drug Discovery Research: Networking Opportunities between Academia & Industries, Birla Institute of Technology and Science, Pilani (April 2006).
  • ‘Pyrrolobenzodiazepine Based Compounds as New Anticancer Agents’, A one day seminar on Recent Developments in Chemistry at University College of Science, Osmania University, Hyderabad (August 2006).
  • ‘Development of New Drugs: Design and Synthesis of New Anticancer Agents’, National Lecture Workshop on Frontiers of Organic Chemistry at St. Pious X Degree & PG College for Women, Hyderabad, sponsored by Indian Academy of Sciences, Bangalore (September 2006).
  • ‘Design of DNA-Binding New Pyrrolobenzodiazepines as Anticancer Agents’, Dr. Reddy’s Laboratories Limited, Hyderabad (October 2006).
  • ‘Design and Synthesis of New Molecules as Potential Anticancer Agents’, Evolva Biotech Hyderabad (November 2006).
  • ‘New Anticancer Agents’, Ranbaxy Research Laboratories, Gurgaon (January 2007).
  • ‘Pyrrolobenzodiazepine Conjugates as Anticancer Agents’, National Seminar on Modern Trends in Supramolecular, Nanotechnology and Nanomedicine, NirmaUniversity, Ahmedabad (March 2007).
  • ‘Chemoenzymatic Processes and the Development of New Anti-cancer Agents’ CSIR, Pretoria, South Africa (July 2007).
  • ‘Greener approaches towards the synthesis of pharmaceutically important compounds’, ISCA 2008: Green-Chemistry Symposium, Andhra University and Vishakhapatnam (January 2008).
  • ‘Efforts in the Development of New Anticancer Agents’ in Indo-French Joint Laboratory for Sustainable Chemistry at Interfaces Symposium, Hyderabad (July 2008)
  • ‘Development of DNA Interactive New Anticancer Agents’ in International Congress on Bioprocesses in Food in Food Industries & 5th Convention of The Biotech Research Society, Osmania University, Hyderabad (November 2008).
  • ‘Approaches Based on Green Chemistry Concept’ in National Seminar on Importance of Green Chemistry in Organic Transformations, Kakinada (November 2008) 
  • ‘Methods Based on Green Chemistry for the Synthesis of Biologically Important Compounds’ at the Indo-Italian Meeting, New Delhi (December 2008)
  • ‘Design and Development of DNA Interactive New Anticancer Agents’ in First World Congress on Cancer, Kerala (January 2009).
  • ‘New Drug Development: Potential Chemotherapeutics for Cancer’ in National Level Seminar on Bio-industry Interaction, CBIT, Hyderabad (January 2009) 
  • ‘Development of DNA Sequence Selective Anticancer Agents’ in National Conference on Recent Advances in Chemical Research, OsmaniaUniversity (February 2009)
  • ‘Gene targeting anticancer pyrrolobenzodiazepines’ in 13th ISCB International Conference on Interplay of Chemical and Biological Science: Impact on Health and Environment, New Delhi (February 2009)
  • ‘Pyrrolobenzodiazepine Conjugates and their prodrugs with a potential for selective therapy of cancer” in National Conference on New Frontiers in Herbal and Synthetic drug Studies (HSDS-2010), Pune (January 2010)
  • ‘Development of New Anticancer Agents’ at Saifabad P.G. College, Hyderabad (Jan 2010)
  • ‘Potential of Pyrrolobenzodiazepine Conjugates as anticancer agents, Syngene   International Ltd, Bangalore ( April 2010)
  • ‘Pyrrolobenzodiazepines as apoptotic anticancer agents’ in AP Science Congress,  JNTU Campus, Hyderabad (August 2010)
  • Dr G Bagavant Memorial Lecture on ‘Development of Pyrrolobenzodiazepines as DNA interactive anticancer agents’ in 15th Annual National Convention of April 2010 at Shilpakala Vedika, Hyderabad (November 2010)
  • ‘Green Chemistry for Pharmaceutical Applications’ in JNTUH-UGC ASC – A Three-Week Refresher Course on “Modern teaching trends in Applied Chemistryat JNTU, Hyderabad (January 2011)
  • ‘Search for Anticancer Agents’ in 17th Annual Symposium on "New Frontiers in Drug Design, Discovery and Development", at National Institute of Immunology, New Delhi (January 2011)
  • ‘DNA Interactive Anticancer Agents’ in RSC MedChem Congress 2011 at National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad (February 2011)
  • ‘Bioactives from Natural Products’ in National Seminar on Chemistry of Bio-Active Natural Products at MVR Degree & PG College, Visakhapatnam (March 2011) 
  • ‘Apoptosis Inducing Ability and Anticancer Activity of New Heterocyclics’ in ILS-Merck Symposium at Hyderabad (April 2011)
  • ‘Recent Developments in Pharmaceutical Sciences’ Symposium at LV Prasad Eye Institute, Hyderabad (August 2011)
  • ‘Advances in Medicinal Chemistry: Challenges in the Development of Anticancer Agents’ in ‘Chemistry in Societal and Environmental Needs’ Symposium at CLRI, Chennai (August 2011)
  • ‘Recent Advances in Medicinal Chemistry: Development of Cancer Therapeutics’ in 2nd PharmSci@India Symposium at National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad (September 2011)
  • ‘Greener  Approaches towards the Development of Pharmaceuticals’ at King Saud University, Saudi Arabia (September 2011)
  • ‘Advances in Medicinal Chemistry: Development of Cancer Therapeutics’, National Symposium on Current Trends in Pharmaceutical Sciences at Birla Institute of Technology & Science, Pilani, Hyderabad Campus (November 2011)
  • ‘Design and Synthesis of New Cancer Therapeutics’, 4th International Chemistry Conference at Riyadh, Saudi Arabia (November 2011)
  • ‘Design and Synthesis of New Cancer Therapeutics’, Healthcare India 2012 International Conference at New Delhi (February 2012)
  • ‘Development of New Antitubercular Agents’, International Conference on Open Source for Computer-Aided Translational Medicine at Chandigarh (February 2012)
  • ‘Advances in Drug Discovery’, Workshop on Modern Chemistry & Biology at Indian Institute of Chemical Technology, Hyderabad (March 2012)
  • ‘Improving Sustainability through Pharmaceutical Green Chemistry’, 5th Saudi Science Conference on ‘A New Vision of the Role of Basic Sciences in Development’ at College of Applied Sciences, Umm Al-Qura University, Makkah, Saudi Arabia (April 2012)
  • ‘Advances in Medicinal Chemistry: Cancer Therapeutics’, at World’s Science Day, Hyderabad (September 2012)
  • ‘Challenges in the Development of Pyrrolobenzodiazepines as Antitumor Antibiotics’, International Conference on Frontiers in Pharmaceutical Sciences: Global Perspectives at University of Rhode Island, USA (September 2012)
  • ‘Scope for Innovations and R&D in Pharmaceutical Clusters’, Workshop on Pharma Networks-Innovation & Infrastructure Development, National Institute of Pharmaceutical Education and Research, Hyderabad (November 2012)
  • ‘21st Century Labs in India’, India Lab Expo & BioLab Analytika 2012’,  Hyderabad (November 2012)
  • ‘Development of New Anticancer Agents’, Darshan Ranganadhan Endowment Lecture, AP Academy of Sciences, Hyderabad (December 2012)
  • ‘Chemo-enzymatic processes for the preparation of chiral intermediates’, Chiral India 2012 Workshop at Hyderabad (December 2012)
  • ‘Role of Scientists in Capacity Building and Innovator as Scientists’, Engineering Staff College of India, Hyderabad (February 2013)
  • ‘Efforts towards the Development of Therapeutics for TB’, 2nd UK-India MedChem Congress, Indian Institute of Chemical Technology, Hyderabad (March 2013)
  • ‘Declining Interest in Science Education and Research: Reasons and Remedies’, Indian Institute of Chemical Technology, Hyderabad (March 2013)
  • ‘Creating Best-in-Class R&D Infrastructure to Spur Innovation’, National Workshop on Drug Discovery and Pharma Innovation Hub 2020, New Delhi (April 2013)
  • ‘Podophyllotoxin congeners as potential anti-cancer agents’ in the National Workshop on Drug Discovery and Development, Central Research Institute of Unani Medicine,Hyderabad (February 2014)
  • ‘Podophyllotoxin congeners as potential anti-cancer agents’ in the 2nd International Conference, Herbals and Synthetic Drug Strategies (HSDS), ISTRA, Pune (February 2014)
  • ‘Podophyllotoxin congeners as potential anti-cancer agents’ in the ISCB International Conference University of Delhi, New Delhi (March 2014)
  • ‘Pyrrolobenzodiazepine and podophyllotoxin: Leads for development of potential anticancer agents’ in the NDCT - 2014, Hyderabad (June 2014)
  • ‘Development of new molecules as potential anticancer agents’  in the CIPLA R&D Centre, Mumbai
  • ‘Drug discovery and development: Pyrrolobenzodiazepines as potential chemotherapeutics’ in the ACTREC, Mumbai (November 2014)
  • ‘Challenges and opportunities in pharmaceutical education and research’ in the AP Science Congress, Hyderabad (November 2014)
  • "Natural products in drug development: Podophyllotoxin congeners as potential chemotherapeutics" in the Central Council for Research in Unani Medicine, New Delhi (February 2015)
  • "Natural products as source of new drugs: Podophyllotoxin congeners as potential chemotherapeutics" in the IACR 2015,34th Annual Convention of Indian Association for Cancer Research, Jaipur (February 2015) 
  • "Medicinal plants in drug discovery:  Podophyllotoxin congeners as potential anticancer agents" in the National Conference on New Frontiers in Medicinal Platns Research (NCMP-2015), Hyderabad (February 2015)
  • Attended EURIE–2018 at Istanbul Ayden University, Turkey on 15th February 2018 and delivered a talk on “New Players in IE: India & Malaysia (Recent trends in higher education in India”.  A Memorandum of Understanding was also signed between Jamia Hamdard and Istanbul Ayden University, Turkey. 
  • Delivered a talk at Yeditepe University, Turkey on “National Products Inspired Development of New Potential Anticancer Agents” on 21st February 2018.
  • Chief Guest at Valedictory function of XXV Quality Improvement programme at DIPSAR, New Delhi on 9th March 2018.
  • Delivered a talk on “Capacity building in Higher Education” organized by the UGC-HRDC, Maulana Azad National Urdu University, and Hyderabad in collaboration with Centre for Academic Leadership and Education Management AMU from April 23rd to April 28th 2018.
  • Delivered a Guest Lecture at CCRUM on “Development of New Anticancer Agents based on Natural Product Scaffolds" on 28th June 2018 at CCRUM, New Delhi. 
  • Delivered at talk on “Translation Research: Need for active Academic Contributions” at Synergy – 2018 at NIPER, Hyderabad on 23rd August 2018. 
  • Chief Guest for the 29th Madina Gold Medal Awards Function by Madina Education & Welfare Society, Hyderabad on 22nd September 2018.
  • Chief Guest for the inaugural function of the Refresher Course in Basic Science (Interdisciplinary) at Jamia Millia Islamia on 26th September 2018.
  • Guest Speaker at the “11th International Opportunities Expo and Career Fair” on October 18, 2018 at National Institute of Health (NIH), Bethesda, Maryland, USA.
  • Chaired the Scientific Session of National Conference in Unani Medicine on “Unani Medicine for Public Health on theme “Emerging Research Trends in Unani Medicine” held on 12th February 2019.
  • Chief Guest in one day International Seminar on “A Review of Experiences and Methods of Religious Education among the Followers of Religions” organized by Al-Mustafa University on 19th February 2019.
  • Chief Guest and delivered Keynote address in a National Conference on “Emerging Trends in Chemical Sciences-2019” at Aligarh Muslim University on 23rd February 2019.
  • Chief Guest and delivered keynote address in the Indian Drugs Annual Day 2019 at Mumbai on 22nd March 2019. 
  • Delivered keynote address in the National Seminar on topic “Efforts in the discovery of cancer chemotherapeutics and development of bioprocesses” held at Jamia Hamdard on 26 March 2019.
  • Visited the Republic of Korea as a delegate in the Higher Education delegation from 7th to 13th April, 2019
  • Attended "2019 India-Taiwan University Vice-Chancellors/Presidents/Directors Forum held at National Institute of Technology, Warangal, Andhra Pradesh on June 21-23, 2019.
  • Visited University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa from 4th – 14th October 2019 under the BRICS collaborative  project
  • Chief Guest for the 1st World History of Unani Medicine Conference – 2019 organized by Nayyar-e-Tibb Hakim Ahmed Ashraf Academy for Public Helath and Medical Heritage held on November 28, 2019.

Quick Links

    An Institution Deemed to be University estd. vide Sec.3 of the UGC Act,1956 under notification # F.12-23/63.U-2 of Jun 18,1964

    © 2022 Centre for Software Development,SDET Unit, BITS-Pilani, India.

    Designed and developed by fractal | ink design studios